ARCHIVES

FDA carries Action On Two Cancer Drugs Over To 1996

This article is from The Cancer Letter archive.

Vol. 22 No. 01 | January 5, 1996

Download PDF Visit The Full Archive

Related Articles

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

June 9, 2006

Family History of BRCA Mutation Does Not Equal Increased Risk

October 28, 2011

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

February 12, 1999

In Brief: Auto Workers Not At Increased risk Of Bladder Cancer, But Truck Drivers Are, New Study Shows

March 11, 1983

In Brief: NCI to Extend Frederick contract To SAIC; Klausner, Gallin, Gail Elected to IOM

October 24, 1996

NCI To Fund Two Construction Grants With 42 Million From Special NIH Fund

March 2, 1990